首页> 外国专利> chemical entities, pharmaceutical compositions, uses of chemical entities or pharmaceutically acceptable compositions, compounds or salts thereof and methods for treating diseases, disorders or medical conditions mediated by pde1 enzyme activity and for modulating pde1 enzyme activity

chemical entities, pharmaceutical compositions, uses of chemical entities or pharmaceutically acceptable compositions, compounds or salts thereof and methods for treating diseases, disorders or medical conditions mediated by pde1 enzyme activity and for modulating pde1 enzyme activity

机译：化学实体，药物组合物，化学实体或药学上可接受的组合物，其化合物或盐的用途以及用于治疗由pde1酶活性介导的疾病，病症或医学病况并调节pde1酶活性的方法

页面导航

摘要
著录项
相似文献

摘要

"Chemical entities, pharmaceutical compositions, uses of chemical entities or pharmaceutically acceptable compositions, compounds or salts thereof and methods for treating diseases, disorders or medical conditions mediated by pde1 enzyme activity and for modulating pde1 enzyme activity" summary are described herein. case compounds and chemical entities of formula I, methods for their synthesis, compositions comprising them and their use in the treatment of numerous disorders, including cognitive deficits associated with snc diseases and disorders. 1/1

机译：本文描述了“化学实体，药物组合物，化学实体或药学上可接受的组合物，其化合物或盐的用途以及用于治疗由pde1酶活性介导的疾病，病症或医学状况并调节pde1酶活性的方法”。式I的化合物和化学实体，其合成方法，包含它们的组合物及其在治疗许多疾病中的用途，包括与snc疾病和疾病相关的认知缺陷。 1/1

著录项

公开/公告号BR112014031731A2

专利类型
公开/公告日2017-06-27

原文格式PDF
申请/专利权人 DART NEUROSCIENCE (CAYMAN) LTD;
展开▼

申请/专利号BR20141131731
发明设计人 AMY ALLAN;BRIAN DYCK;BRYAN BRANSTETTER;LAURENT GOMEZ;MARCO PETERS;MICHAEL I. WEINHOUSE;TAMMI JO MARRONE;
展开▼

申请日2013-06-18
分类号C07D487/14;A61K31/519;A61P9;A61P25;
国家 BR
入库时间 2022-08-21 13:40:23

相似文献

专利
外文文献
中文文献